[United States Statutes at Large, Volume 128, 113th Congress, 2nd Session]
[From the U.S. Government Publishing Office, www.gpo.gov]


Public Law 113-280
113th Congress

An Act


 
To reauthorize the United States Anti-Doping Agency, and for other
purposes. <>

Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled, <>
SECTION 1. <>  SHORT TITLE.

This Act may be cited as the ``United States Anti-Doping Agency
Reauthorization Act''.
SEC. 2. PROHIBIT PERFORMANCE-ENHANCING METHODS.

Section 701 of title VII of the Office of National Drug Control
Policy Reauthorization Act of 2006 (21 U.S.C. 2001) is amended--
(1) in subsection (a), by striking paragraph (4); and
(2) in subsection (b)--
(A) in paragraph (1), by inserting ``and be
recognized worldwide as the independent national anti-
doping organization for the United States'' after
``Committee'';
(B) in paragraph (2), by striking ``, or
performance-enhancing genetic modifications accomplished
through gene-doping'' and inserting ``or prohibited
performance-enhancing methods adopted by the Agency'';
(C) in paragraph (3), by striking ``, or
performance-enhancing genetic modifications accomplished
through gene-doping'' and inserting ``or prohibited
performance-enhancing methods adopted by the Agency'';
(D) in paragraph (4), by striking ``and the
prevention of use of performance-enhancing drugs, or
performance-enhancing genetic modifications accomplished
through gene-doping by United States amateur athletes;
and'' and inserting ``, and the prevention of use by
United States amateur athletes of performance-enhancing
drugs or prohibited performance-enhancing methods
adopted by the Agency.''; and
(E) by striking paragraph (5).
SEC. 3. AUTHORIZATION OF APPROPRIATIONS.

Section 703 of title VII of the Office of National Drug Control
Policy Reauthorization Act of 2006 (21 U.S.C. 2003) is amended to read
as follows:
``SEC. 703. AUTHORIZATION OF APPROPRIATIONS.

``There are authorized to be appropriated to the United States Anti-
Doping Agency--
``(1) for fiscal year 2014, $11,300,000;
``(2) for fiscal year 2015, $11,700,000;

[[Page 3021]]

``(3) for fiscal year 2016, $12,300,000;
``(4) for fiscal year 2017, $12,900,000;
``(5) for fiscal year 2018, $13,500,000;
``(6) for fiscal year 2019, $14,100,000; and
``(7) for fiscal year 2020, $14,800,000.''.

Approved December 18, 2014.

LEGISLATIVE HISTORY--S. 2338:
---------------------------------------------------------------------------

HOUSE REPORTS: No. 113-
281 (Comm. on Commerce, Science, and Transportation).
CONGRESSIONAL RECORD, Vol. 160 (2014):
Dec. 11, considered and passed Senate.
Dec. 12, considered and passed House.